BioSpace News Archive

Laser Medical Canada of Laval, Quebec, has pleaded guilty to charges related to illegally selling and advertising unlicensed medical devices, providing false statements to Health Canada inspectors, and interfering with seized products.

The Vascular Care Group, a state-of-the art practice committed to the prevention, diagnosis and treatment of vascular disease, announced the hiring of Sebastian DiDato, MD, FACS, RPVI, MPH to its Leominster, Mass.

Novel Entactogen NCE Series Enhances the Potential for Improved Treatment of Addiction.

Hardy Diagnostics announces new TRIO.SETTLE stands, specially designed for passive microbial air monitoring.

Over 150 presenting Medtech startup companies and over 100 investors will come together for the third annual Life Science Intelligence (LSI) USA ’22 Emerging Medtech Summit.

Synergy Biomedical, LLC, a developer of innovative bone graft products for spine and orthopedic surgery, announced the publication of a basic science study describing the findings and scientific strategies of controlling the bone formation response of bioactive glass.

Lucile Packard Children’s Hospital Stanford, the center of Stanford Children’s Health, has been verified as a Level I children’s surgery center by the American College of Surgeons Children’s Surgery Verification Program—the highest designation a hospital can receive.

University Lab Partners (ULP), the premier, non-profit, wet lab/medtech incubator located in UCI Research Park, celebrates its 2-year anniversary with 100% capacity.

Synthetic Biologics, Inc. (NYSE American: SYN), a diversified clinical-stage company developing therapeutics designed to treat diseases in areas of high unmet need, today announced that the Company will be presenting at the B. Riley Securities Oncology Conference being held virtually on January 27-28, 2022.

Epizyme, Inc., a fully integrated, commercial-stage biopharmaceutical company developing and delivering novel epigenetic therapies, announced that it intends to offer and sell shares of its common stock in an underwritten public offering.